Search

The Role of Toll-Like Receptors and Type I Interferons in Host Responses to Bacteria

Journal: Current Immunology Reviews
Volume: 5 Issue: 2 Year: 2009 Page: 143-149
Author(s): Marja Ojaniemi, Mari Liljeroos, Reetta Vuolteenaho

Interferon-α / β-Receptor Interactions: A Complex Story Unfolding

Journal: Current Pharmaceutical Design
Volume: 8 Issue: 2 Year: 2002 Page: 2131-2137
Author(s): Raj Deonarain, David C.M. Chan, Leonidas C. Platanias, Eleanor N. Fish

In Silico Study of Mutations on Binding between Interferon Alpha 2b and IFNAR1 Receptor

Journal: Current Proteomics
Volume: 15 Issue: 1 Year: 2018 Page: 71-76
Author(s): Samira Talebi,Alireza Saeedinia,Mehdi Zeinoddini,Fathollah Ahmadpour,Majid Sadeghizadeh

The Chemokine System as a Therapeutic Target in Autoimmune Thyroid Diseases: A Focus on the Interferon-γ Inducible Chemokines and their Receptor

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 3202-3216
Author(s): Mario Rotondi, Luca Chiovato

Innate Immune Receptors and IRF Family Transcription Factors

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 4 Issue: 1 Year: 2005 Page: 29-33
Author(s): Takashi Fujita, Mitsutoshi Yoneyama

Quasi-Life Self-Organizing Systems: Based on Ensembles of Succinylated Derivatives of Interferon-Gamma

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 3431-3436
Author(s): A. Martynov, B. Farber, S. Farber

Small Molecule and Biologic Modulators of the Immune Response to Hepatitis C Virus

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 6 Issue: 5 Year: 2006 Page: 527-531
Author(s): M. L. Mbow, A. Eaton-Bassiri, W. G. Glass, A. M. Del Vecchio, R. T. Sarisky

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 10 Issue: 2 Year: 2011 Page: 73-77
Author(s): Charles J. Malemud

Antiviral Sensing in Teleost Fish

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 4185-4193
Author(s): Jun Zou, Steve Bird, Chris Secombes

Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways

Journal: Current Cancer Drug Targets
Volume: 9 Issue: 5 Year: 2009 Page: 690-704
Author(s): M. Caraglia, M. Marra, P. Tagliaferri, S. W.J. Lamberts, S. Zappavigna, G. Misso, F. Cavagnini, G. Facchini, A. Abbruzzese, L. J. Hofland, G. Vitale